Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer

Detailed price information for Nuvation Bio Inc (NUVB-N) from The Globe and Mail including charting and trades.
The Malaysian Reserve

FDA Approves Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal Phase 3 IMforte trial Zepzelca and atezolizumab ...
Frontiers

Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database

1 Department of Dermatology, Guanganmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China 2 College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, ...